The diabetic foot ulcers: Anti-infectious strategies;Troubles trophiques du pied chez le diabétique: Stratégie anti-infectieuse

Annales de Medecine Interne

Volumn 152, Issue 5, 2001, Pages 305-316

  Somme, Dominique ^a   Reny, Jean Luc ^b   Mainardi, Jean Luc ^c  

^a Service de Geriatrie   (France)

^b Service de Médecine Vasculaire   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Antibiotherapy; Diabetes; Foot ulcers; Infection

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GLUCOSE; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; PRISTINAMYCIN; TIMENTIN; VANCOMYCIN;

ALGORITHM; ANTIMICROBIAL ACTIVITY; BONE TISSUE; DIABETIC FOOT; DIAGNOSTIC APPROACH ROUTE; DRUG INDICATION; DRUG TISSUE LEVEL; FOOT AMPUTATION; GLUCOSE BLOOD LEVEL; HUMAN; INFECTION; INFECTION PREVENTION; REVIEW;

ALGORITHMS; AMPUTATION; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BLOOD GLUCOSE; COMBINED MODALITY THERAPY; DEBRIDEMENT; DECISION TREES; DIABETIC FOOT; DRUG RESISTANCE; HUMANS; INFECTION CONTROL; MICROBIAL SENSITIVITY TESTS; PATIENT SELECTION; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SKIN CARE; WOUND INFECTION;

EID: 0034770198     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Evidence-based antibiotic therapy of diabetic foot infections
2. Pharmacotherapy of lower limb diabetic ulcers
3. Osteomyelitis in the feet of diabetic patients. Long-term results, prognostic factors, and the role of antimicrobial and surgical therapy
4. Outcome of diabetic foot infections treated conservatively: A retrospective cohort study with long-term follow-up
5. Assessment and management of foot disease in patients with diabetes
6. Unsuspected osteomyelitis in diabetic foot ulcers. Diagnosis and monitoring by leukocyte scanning with indium in 111 oxyquinoline
7. Foot infections in diabetic patients. Decision and cost-effectiveness analyses
8. Prognostic value of the clinical examination of the diabetic foot ulcer
9. Bacteriology of 100 consecutive diabetic foot infections and in vitro susceptibility to ampicillin/sulbactam versus cefoxitin
10. The infected foot of the diabetic patient: Quantitative microbiology and analysis of clinical features
11. Diabetic foot infections. Antimicrobial therapy
12. Wound classification is more important than site of ulceration in the outcome of diabetic foot ulcers
13. The dysvascular foot: A system for diagnosis and treatment
14. Probing to bone in infected pedal ulcers. A clinical sign of underlying osteomyelitis in diabetic patients
15. Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus, peripheral vascular disease, or both
16. Osteomyelitis of the foot in diabetic patients evaluation with plain film, 99mTc-MDP bone scintigraphy, and MR imaging
17. Effect of soft-tissue pathology of detection of pedal osteomyalitis in diabetics
18. Diagnosis of pedal osteomyelitis in diabetic patient using current scintigraphic techniques
19. The diabetic foot: Magnetic resonance imaging evaluation
20. Leukocyte scanning with 111In is superior to magnetic resonance imaging in diagnosis of clinically unsuspected osteomyelitis in diabetic foot ulcers
21. Osteomyelitis of the foot in diabetic patients
22. Diabetic foot infections. Bacteriologic analysis
23. Microbiology of superficial and deep tissues in infected diabetic gangrene
24. Diagnostic value of sinus-tract cultures in chronic osteomyelitis
25. Microbiology of osteomyelitis in diabetic foot infections
26. Outpatient management of uncomplicated lower-extremity infections in diabetic patients
27. Antibiotic treatment for uncomplicated neuropathic forefoot ulcers in diabetes: A controlled trial
28. Cost effectiveness of early digit amputation in the patient with diabetes
29. Can aggressive treatment of diabetic foot infections reduce the need for above-ankle amputation?
30. Oral antibiotic therapy for osteomyelitis of the foot in diabetic patients
31. Antibiotic therapy for diabetic foot infections: Comparison of two parenteral-to-oral regimens
32. Diffusion in bone tissue of antibiotics
33. Staphylococcal osteomyelitis - A comparison of co-amoxiclav with clindamycin and flucloxacillin in an experimental rat model
34. Tissue and serum concentrations of amoxycillin and clavulanic acid in patients having reconstructive vascular surgery
35. Comparison of serum and tissue antibiotic levels in diabetes-related foot infections
36. Amoxicillin/clavulanic acid in therapy of bacterial infections of the diabetic foot. Results of an observational study
37. Toxicities of antimicrobial agents used to treat osteomyelitis
38. In vitro activity of 10 antibiotics including pristinamycin and its two components (RP 12536 and 27404) against strict anaerobes
39. Tissue penetration of clindamycin in diabetic foot infections
40. Penetration of cloxacillin into human bone tissue after oral administration
41. Foot infections in diabetics: The antibiotic choice
42. Quinolone activity against anaerobes
43. Use of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients
44. Deep foot infections in patients with diabetes and foot ulcer: An entity with different characteristics, treatments, and prognosis
45. Treatment of hospitalized patients with complicated skin and skin structure infections: Double-blind, randomized, multicenter study of piperacillin-tazobactam versus ticarcillin-clavulanate
46. Cost-effectiveness of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients
47. Management and outcome of severe diabetic foot infections
48. Multicenter study of in vitro susceptibility of the Bacteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996
49. Prevalence of resistance to MLS antibiotics in 20 European university hospitals participating in the European SENTRY surveillance programme. Sentry Participants group